Median Technologies: H2 2025 Financial Communication Calendar

About this update from Median Technologies

SOPHIA ANTIPOLIS, France, September 08, 2025 --( BUSINESS WIRE )--Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company") , manufacturer of eyonis ® , a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, announces today its H2 2025 financial communication calendar. The Company will participate in upcoming investor events: European MidCap Event 2025 September 30 – October 1st, 2025 - Paris, France Portzamparc Biotech and Healthcare Sector Investor Seminar October 1-2, 2025 (digital) Investor Access Conference 2025 October 7-8, 2025 - Paris, France Please get in touch through the respective event booking systems, if you would like to request a meeting with Median management at these events. Events are for institutional investors only. About Median Technologies: Pioneering innovative software as a medical device and imaging services, Median Technologies harnesses cutting-edge AI to enhance the accuracy of early cancer diagnoses and treatments. Median's offerings include iCRO, which provides medical image analysis and management in oncology trials, and eyonis ® , an AI/ML tech-based suite of software as a medical device (SaMD). Median empowers biopharmaceutical entities and clinicians to advance patient care and expedite the development of novel therapies. The French-based company, with a presence in the U.S. and China, trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is also eligible for the French SME equity savings plan scheme (PEA-PME). For more information, visit www.mediantechnologies.com . View source version on businesswire.com: https://www.businesswire.com/news/home/20250908162115/en/ Contacts MEDIAN TECHNOLOGIES Emmanuelle Leygues VP, Corporate Marketing & Financial Communications +33 6 10 93 58 88 [email protected] Investors - SEITOSEI ACTIFIN Ghislaine Gasparetto +33 6 85 36 76 81 [email protected] U.S. media & investors - COHESION BUREAU Chris Maggos +41 79 367 6254 [email protected] Press – ULYSSE COMMUNICATION Bruno Arabian +33 6 87 88 47 26 [email protected] Nicolas Entz +33 6 33 67 31 54 [email protected]

View stock analysis, news, and events for Median Technologies